CAMBRIDGE, Mass., Sept. 25 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview, including an update of the company's clinical program, at the upcoming UBS 2006 Global Life Sciences Conference on Wednesday, September 27, 2006 at 11:30 a.m. ET at the Grand Hyatt New York.
The live and archived webcast of the presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://ir.idenix.com/phoenix.zhtml?c=131556&p=irol-calendar. Please log in approximately 10 minutes before the call to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the presentation.
About Idenix
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). Idenix's headquarters are located in Cambridge, Massachusetts and it has drug discovery operations in Montpellier, France and Cagliari, Italy.
Contact:
Idenix Pharmaceuticals, Inc.
Amy Sullivan (617) 995-9838
Idenix Pharmaceuticals, Inc.CONTACT: Amy Sullivan of Idenix Pharmaceuticals, Inc., +1-617-995-9838
Web site: http://www.idenix.com//
